MRNA

Moderna
D

MRNA

41.820
USD
2.45
(6.22%)
مغلق
حجم التداول
606,130
الربح لكل سهم
-8
العائد الربحي
-
P/E
-5
حجم السوق
16,340,480,658
التوصيات
Strategic Pips
Strategic Pips
منذ 9 أشهر
buy
MRNA
MRNA @26.15
2025-04-14 06:32
MRNA@26.15 Chart
الربح
2,350.50
59.92%
Strategic Pips
Strategic Pips
منذ سنة
sell
MRNA
MRNA @101.02
2024-02-01 03:45
MRNA@101.02 Chart
الربح
8,880.00
58.60%
Strategic Pips
Strategic Pips
منذ سنة
sell
MRNA
MRNA @101.83
2024-01-29 04:09
MRNA@101.83 Chart
الربح
9,001.50
58.93%
المزيد
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ سنة
neutral
2024-10-01 04:30
MRNA Chart
المزيد
أصول ذات صلة الأخبار المقالات

العنوان: Moderna

القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.